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Ubiquitination of proteins is an abundant mod-
ification that controls numerous cellular pro-
cesses. Many Ubiquitin (Ub) protein ligases
(E3s) target both their substrates and them-
selves for degradation. However, the mecha-
nisms regulating their catalytic activity are
largely unknown. The C2-WW-HECT-domain
E3 Smurf2 downregulates transforming growth
factor-b (TGF-b) signaling by targeting itself,
the adaptor protein Smad7, and TGF-b receptor
kinases for degradation. Here, we demonstrate
that an intramolecular interaction between the
C2 and HECT domains inhibits Smurf2 activity,
stabilizes Smurf2 levels in cells, and similarly in-
hibits certain other C2-WW-HECT-domain E3s.
Using NMR analysis the C2 domain was shown
to bind in the vicinity of the catalytic cysteine,
where it interferes with Ub thioester formation.
The HECT-binding domain of Smad7, which ac-
tivates Smurf2, antagonizes this inhibitory inter-
action. Thus, interactions between C2 and
HECT domains autoinhibit a subset of HECT-
type E3s to protect them and their substrates
from futile degradation in cells.
INTRODUCTION
Posttranslational attachment of Ubiquitin (Ub) marks pro-
teins for various cellular fates and functions, including pro-
teasomal degradation, endocytosis, endosomal sorting,
and DNA repair. In general, three enzymes catalyze the
ubiquitination reaction: a Ub-activating enzyme (E1), a Ub-
conjugating enzyme (E2), and a specificity-determining
Ub-protein ligase (E3; Herschko and Ciechanover,
1998). Ub ligases fall into two categories; HECT domainE3s form a Ub thioester intermediate via a strictly con-
served cysteine residue, while RING finger and U-box
E3s act as scaffolding proteins that indirectly enhance
Ub transfer from the E2 conjugate to the substrate. One
class of HECT domain E3s is characterized by a common
modular organization with an N-terminal C2 domain that
can mediate membrane localization, two to four WW do-
mains that recognize proline-rich motifs of substrates or
adaptor proteins, and a C-terminal HECT domain that cat-
alyzes isopeptide bond formation between theUbC termi-
nus and the substrate lysine residue (Ingham et al., 2004).
Although ubiquitination has important implications for
cellular function, the mechanisms that regulate the ubiqui-
tination reaction are largely unknown. Smurf1 (Smad
ubiquitination-related factor 1) and Smurf2 are closely
related C2-WW-HECT-domain E3s that play important
roles in the downregulation of the TGF-b signaling path-
way (Kavsak et al., 2000; Zhu et al., 1999). TGF-b proteins
are key morphogens that control a variety of develop-
mental processes, including cell growth, differentiation,
and self-renewal. Interaction of TGF-b morphogens with
TGF-b receptor complexes initiates intracellular signaling
cascades involving Smad proteins (Feng and Derynck,
2005) and the polarity protein Par6 (Ozdamar et al.,
2005). Upon TGF-b-induced expression, the inhibitory
adaptor protein Smad7 forms a complex with the Smurf2
Ub ligase in the nucleus (Kavsak et al., 2000). Association
of Smurf2 with Smad7 serves at least three regulatory
functions; it stimulates Smurf activity by recruiting the E2
to the HECT domain (Ogunjimi et al., 2005), induces the
export of the Smurf2-Smad7 complex to the cytoplasm,
and mediates its interaction with TGF-b receptors result-
ing in the ubiquitination of TGF-b receptors, Smad7,
and Smurf2 itself to ultimately terminate TGF-b signaling
(Kavsak et al., 2000).
Smurf proteins also regulate cell shape, motility, and
polarity by degrading small guanosine triphosphatases
(GTPases). While Smurf2-dependent degradation of the
GTPase Rap1B is required for the establishment of neuro-
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polarized epithelial cells (Ozdamar et al., 2005; Schwam-
born et al., 2007; Wang et al., 2003). Smurf1 activity to-
ward RhoA is spatially restricted tomembrane protrusions
in migrating cells or tight junction regions in epithelial cells
by the polarity proteins atypical protein kinase C and Par6
(Ozdamar et al., 2005; Wang et al., 2003). Growing evi-
dence suggests that dysregulation of Smurf-dependent
degradation of components of TGF-b signaling pathways
leads to developmental defects and plays important roles
in cancer pathogenesis and metastasis (Izzi and Attisano,
2004).
Ubiquitination is one of the most abundant posttransla-
tional protein modifications. Yet, it is poorly understood
how the ubiquitination machinery itself is regulated to pre-
vent autocatalytic degradation of the core components.
Although Ub protein ligases have largely been considered
to be constitutively active and regulated only at the level of
target binding, it has become evident recently that HECT-
type E3s are subject to regulation either by E3 or substrate
phosphorylation or by utilization of adaptor proteins that
facilitate E2 recruitment (Kee and Huibregtse, 2007).
Here, we report the solution structure of the N-terminal
Smurf2 C2 domain and show that it interacts with the
C-terminal HECT domain in the vicinity of the catalytic
cysteine. This interaction inhibits Smurf2 Ub ligase activity
in vitro and in vivo by interfering with Ub thioester for-
mation and serves to stabilize Smurf2 and substrate
steady-state levels in cells. We propose a model for the
regulation of the HECT-type Ub ligase Smurf2 through
intra- and intermolecular interactions.
RESULTS
The C2 Domain, but Not the WW1 Domain,
Interacts with the HECT Domain of Smurf2
To investigate whether the catalytic activity of the C2-
WW-HECT-E3 Smurf2 is regulated by intramolecular
domain-domain interactions, we explored potential inter-
actions between the Smurf2 C2 or WW1 domain and the
HECT domain using NMR chemical shift perturbation
studies. In combination with resonance assignments and
3D protein structures, NMR titrations provide direct infor-
mation about which residues are located in binding sites.
The crystal structure of a Smurf2 WW2-WW3-HECT do-
main construct revealed no electron density for the two
WW domains (Ogunjimi et al., 2005), indicating that they
are not likely engaged in a stable intramolecular inter-
action with the HECT domain. Therefore we focused our
efforts on the N-terminal C2 domain and the first WW
domain.
Addition of Smurf2 WW1 domain to 15N-labeled HECT
domain resulted in no significant chemical shift changes
in the 1H,15N-correlation (HSQC) spectrum of the HECT
domain even at a large excess ofWW1domain (Figure 1A).
Thus, the Smurf2 WW1 domain does not interact with the
HECT domain when added as an isolated polypeptide. In
contrast, addition of Smurf2 C2 domain to 15N-labeled
HECT domain resulted in numerous chemical shift652 Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc.changes in the 1H,15N-HSQC spectrum of the HECT do-
main (Figure 1B). In a complementary experiment, titration
of the HECT domain to the 15N-labeled C2 domain also
resulted in significant chemical shift changes in the
1H,15N-HSQC spectrum of the C2 domain (Figure 1C).
Furthermore, stepwise addition of the ligand increased
line-broadening in both spectra due to the higher molecu-
lar weight of the complex formed (62 kD). Together,
these data demonstrate that the N-terminal C2 domain
of Smurf2 binds the C-terminal HECT domain, even
when added as an isolated polypeptide.
Solution Structure of the Smurf2 C2 Domain
In order to map the residues affected by HECT domain
binding onto the structure of the C2 domain, we assigned
>98% of all 1H, 13C, and 15N resonances of the Smurf2 C2
domain and determined its solution structure by hetero-
nuclear NMR spectroscopy. As shown in Figure 2A, the
ensemble of the 20 lowest-energy NMR structures is
well defined except for loop regions. Structural statistics
are summarized in Table S1. The Smurf2 C2 domain
adopts the typical C2 domain b sandwich fold composed
of two four-stranded, antiparallel b sheets (Figure 2B). The
fold also contains two a helices that connect b strands
5 and 6 (aa 82-87; aI) and b strands 6 and 7 (aa 107-116;
aII). Overall, the structure of the Smurf2 C2 domain is
very similar to those of other C2 domains with a backbone
RMSD of 2.8 A˚ when compared to the PKCa C2 domain
in complex with two Ca2+-ions and phosphatidyl serine
(PDB ID: 1DSY; Figures 2B and 2C).
Although C2 domains share a common fold, they exhibit
at least two different secondary structure topologies that
are achieved by a circular permutation of the b strands
placing the N- and C terminus at either the top (class I)
or bottom (class II) of the b sandwich andmay have a short
a helix either between strands b7 and b8 (class IB) or be-
tween strands b6 and b7 (class IIB; Ubach et al., 1999). To-
gether with the relatively low overall sequence similarity,
these alternative secondary structure topologies repre-
sent potential pitfalls for the homology modeling of C2 do-
main structures. Based on our solution structure, the
Smurf2 C2 domain can clearly be identified as a class
IIB C2 domain (Figure 2B). Furthermore, sequence similar-
ity amongC2 domains of Nedd4/Rsp5p-family proteins in-
dicates that the class II C2 domain fold is evolutionarily
conserved across the entire family of C2-WW-HECT-
domain Ub ligases (Figure S1).
The Smurf2 C2 Domain Interacts
with Phosphoinositides via an Interface
that Overlaps with the HECT Domain Binding Site
With a full resonance assignment and the solution struc-
ture of the Smurf2 C2 domain in hand, wemapped the res-
idues affected by HECT domain binding (Figure 1C). This
revealed that the HECT domain interacts with a hydropho-
bic and positively charged surface patch on the C2
domain that is composed of residues in the b1-b2 and
b3-b4 loops, the aI helix, and the aI-b6 loop (Figures 3A
Figure 1. The C-Terminal Catalytic HECT Domain of Smurf2
Interacts Directly with the N-Terminal C2 Domain, but Not
with the WW1 Domain
(A) Overlay of representative regions of 1H,15N-HSQC spectra of par-
tially deuterated, 15N-labeled Smurf2 HECT domain in the absence
(black; reference spectrum) and presence of increasing concentra-
tions of unlabeled Smurf2 WW1 domain (molar HECT:WW1 domain
ratios: 1:4 [red]; 1:8 [green]).and S2A). C2 domains were first identified as phospho-
lipid-binding modules (Rizo and Sudhof, 1998). To
characterize Smurf2 C2 domain-phospholipid interac-
tions in more detail, we performed protein lipid overlay
assays. Of all 15 lipids tested, the Smurf2 C2 domain
interacted with phosphatidyl mono-, bi-, and triphos-
phates (PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,4)P2,
PtdIns(3,5)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3) and
with phosphatidic acid (PA) in a Ca2+-independentmanner
(Figure S2B). Except for the PA interaction, these results
are in close agreement with the phospholipid-binding
specificities of Rsp5p (Dunn et al., 2004). Using NMR titra-
tions with unlabeled Ins(1,3,5)P3 and
15N-labeled Smurf2
C2 domain (Figure S2C), we mapped the phospholipid-
binding surface to hydrophobic and positively charged
C2 domain residues in the b1-b2 loop, the b5-b6 loop in-
cluding helix aI, and the b7-b8 loop (Figure 3B). This
Ins(1,3,5)P3 binding site is consistent with the close struc-
tural similarity to the PKCa C2 domain complex (Fig-
ure 2C). Interestingly, comparison of the phosphoinositide
and HECT domain binding sites on the C2 domain re-
vealed substantial spatial overlap (Figures 3A–3B, S2A,
and S2C). Altogether, these results suggest a dual role for
C2 domains in HECT domain and phospholipid binding.
The Smurf2 C2 Domain Binds the HECT Domain
in Direct Proximity to the Catalytic Cysteine
We next sought to map the C2 domain binding surface on
the HECT domain. Since wewere unable to identify condi-
tions under which the Smurf2 HECT domain would be
stable over the time required for traditional backbone-
directed resonance assignment experiments, we em-
ployed an isotope labeling scheme recently developed
for the study of high molecular weight proteins (>100 kD;
Tugarinov et al., 2003). Using Smurf2 HECT domain exclu-
sively labeled at isoleucine-d1 positions, we obtained
high-quality 1H,13C-correlation (HMQC) methyl spectra
that could be used for chemical shift mapping studies
(Figure 3C). This approach is thus a useful alternative to
1H,15N-based chemical shift perturbation studies for pro-
teins with limited stability and/or solubility. As in the
1H,15N-based chemical shift titration (Figure 1B), a subset
of resonances of the Smurf2 HECT domain changed in the
methyl HMQC spectra upon stepwise addition of the C2
domain (Figure 3C).
To map the isoleucine residues affected by C2 domain
binding onto the structure of the HECT domain, we gener-
ated six isoleucine mutants of the Smurf2 HECT domain
and compared their 1H,13C methyl spectra with that of
(B) As in (A), but in the presence of increasing concentrations of unla-
beled Smurf2 C2 domain (molar HECT:C2 domain ratios: 2:1 [red];
1:1 [green]; 1:4 [blue]).
(C) As in (A), but for partially deuterated, 15N-labeled Smurf2 C2 do-
main and increasing concentrations of unlabeled Smurf2 HECT do-
main (molar C2:HECT domain ratios: 2:1 [red]; 1:1 [green]; 1:4 [blue]).
Significant chemical shift changes are indicated by arrows in panels
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the wild-type HECT domain. In a previous experiment, the
catalytic cysteine-containing HECT domain C-lobe was
not sufficient for an interaction (Figure S3). Therefore, we
mutated isoleucine residues in the N-lobe close to the ac-
tive site cysteine or located at the interface between theN-
and C-lobes (Figure S4A). Comparison of the mutant and
wild-type spectra resulted in the unambiguous assign-
ment of four of the six isoleucine mutants (Figure S4B).
Figure 2. Solution Structure of the Smurf2 C2 Domain
(A) Stereoview of the ensemble of 20 lowest-energy NMR structures
out of 100 structures calculated. The backbone trace is shown in
gray, while a helices and b strands are highlighted in yellow and
blue, respectively.
(B) Ribbon representation of the lowest-energy structure color-coded
as in (A). The secondary structure topology of the Smurf2 C2 domain is
indicated on the bottom.
(C) Structural superposition of the class II Smurf2 C2 domain (gray) and
the class I PKCa C2 domain in complex with Ca2+-ions and phospha-
tidyl serine (PDB ID: 1DSY; shown in green). The class I secondary
structure topology of the PKCa C2 domain is indicated in green on
the bottom.654 Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc.Intriguingly, the isoleucine residues affected byC2 domain
binding (I402 and I489) map to a hydrophobic/acidic sur-
face patch in direct vicinity of the catalytic cysteine
(C716) of the HECT domain (Figures 3D and S5). This sug-
gests a regulatory function for the interaction between the
C2 and HECT domains.
The Interaction of the Smurf2 C2 and HECT
Domains Inhibits Ub Thioester Formation
To test whether the interaction between the Smurf2 C2
and HECT domains indeed regulates HECT domain activ-
ity, we performed Ub thioester assays with wild-type
Smurf2, a Smurf2 mutant lacking the C2 domain (Smurf2
DC2) and catalytically inactive Smurf2. In the latter, the ac-
tive-site cysteine was mutated to alanine (CA mutant).
Protein levels of unmodified and ubiquitinated Smurf2
were analyzed by SDS-PAGE in the presence or absence
of DTT as reducing agent and immunoblotting with a-
Smurf2 antibody. In preliminary experiments, theDC2mu-
tant ubiquitinated itself so efficiently that isopeptide-
linked monoubiquitinated DC2 obscured the formation of
DTT-sensitive Ub thioester adducts (data not shown).
Therefore, we used Smurf2 variants truncated by four res-
idues from their C-termini (‘‘4aa’’) in subsequent Ub thio-
ester assays, as this abolishes Ub isopeptide-linkage
without affecting thioester formation (Salvat et al., 2004).
No ubiquitination of wild-type –4aa Smurf2 was observed
in the Ub thioester assays (Figure 3E). In contrast, the
DC2 –4aa mutant readily formed thioester-, but not
isopeptide-linked Ub adducts, as revealed by the pres-
ence of a reduction-sensitive DC2Ub adduct. Together
with the chemical shift mapping studies (Figures 3C–3D),
these results suggest that the C2 domain inhibits Smurf2
activity by obstructing accessibility of the catalytic cys-
teine of the HECT domain, thus blocking Smurf2Ub
thioester formation.
Deletion of the C2 Domain Enhances Smurf2
Autoubiquitination In Vitro
Having established an inhibitory role of the C2 domain for
Smurf2 function, we next addressed the effect of the C2
domain on Smurf2 autoubiquitination. To this end we per-
formed in vitro ubiquitination assays using wild-type
Smurf2, the DC2 mutant, and the isolated Smurf2 HECT
domain. Protein levels of unmodified and ubiquitinated
Smurf2 at different time points in the reaction were ana-
lyzed by SDS-PAGE and immunoblotting with a-Smurf2
and a-Ub antibodies. As shown in Figures 4A and S6,
the level of unmodified wild-type Smurf2 did not change
significantly during the course of the reaction (top panel),
with little ubiquitinated Smurf2 detected after 2 hr (bottom
panel). In contrast, most of the coreDC2protein wasmod-
ified to ubiquitinated species by the end of the reaction in
a manner similar to the isolated HECT domain (Figures 4A
and S6). Thus, deletion of the C2 domain enhances auto-
ubiquitination of Smurf2. Of note, our previous work
revealed a role for Smad7 in stimulating Smurf2 ubiquiti-
nation by facilitating E2 binding to the HECT domain
Figure 3. Chemical Shift Mapping of the Smurf2 C2 and HECT Domain Interaction Surfaces
(A) Chemical shift mapping of the Smurf2 HECT domain binding site on the C2 domain structure. Residues experiencing significant chemical shift
changes (DdAvR 0.02 ppm) are colored with a linear gradient from white (DdAv% 0.02 ppm) to red (DdAv = 0.22 ppm). Spheres represent the nitrogen
atoms of affected residues. Average chemical shift changes in proton and nitrogen were calculated as follows: DdAv = ([Dd1H]
2 + [Dd15N]
2/5)1/2. Arrows
highlight C2 domain residues most affected by ligand binding.
(B) As in (A), but for Ins(1,3,5)P3 binding and using a linear gradient from white (DdAv% 0.02 ppm) to blue (DdAv = 0.22 ppm).
(C) Overlay of representative regions of the 1H,13C-HMQC spectra of U-Ile d1-[1H,13C]-labeled Smurf2 HECT domain in the absence (black; reference
spectrum) and presence of increasing concentrations of unlabeled Smurf2 C2 domain (molar HECT:C2 domain ratios: 1:1 [red]; 1:4 [green]).
(D) Chemical shift mapping of the Smurf2 C2 domain binding site on the HECT domain structure (PDB ID: 1ZVD). Ile residues experiencing significant
chemical shift changes are shown in green as sticks, while spheres represent their d1 methyl carbon atoms. The active site cysteine (C716) located in
proximity to the C2 domain binding site (circled) is highlighted in orange.
(E) Deletion of the Smurf2 C2 domain enables Smurf2 Ub thioester formation. Wild-type, catalytically inactive (CA), and DC2 Smurf2 truncated by four
residues from the C terminus (4aa) were expressed in bacteria and purified for Ub thioester assays. After an incubation time of 10 min, the reactions
were divided in two and stopped with SDS-PAGE loading buffer without (top panel) or with DTT (bottom panel). Smurf2 protein was detected by im-
munoblotting with a-Smurf2 antibody.(Ogunjimi et al., 2005). Consistent with these findings, ad-
dition of Smad7 to the DC2 mutant further enhances
Smurf2 ubiquitination (data not shown).
Interfering with the C2 and HECT Domain
Interface Enhances Smurf2 Autoubiquitination
In Vitro
Based on the results of the NMR analysis, we introduced
site-directed C2 domain mutations into full-length Smurf2
that were designed to interfere with the interaction be-
tween the C2 and HECT domains. C2 domain residuesthat displayed themost significant chemical shift perturba-
tions uponHECT domain binding (Figure 3A) weremutated
to alanine in the case of hydrophobic residues and to glu-
tamate for basic residues. In total, we generated six mu-
tants and tested their autoubiquitination efficiency by com-
paring protein levels of unmodified and ubiquitinated
Smurf2 (Figure 4B). Smurf2 variants in which the C2 do-
main hydrophobic residues involved in HECT domain bind-
ing were mutated (F29A/F30A and T56A/L57A) displayed
the highest ubiquitination levels. These residues also
displayed the largest chemical shift changes upon HECTCell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc. 655
Figure 4. The Interaction between the C2 and HECT Domains Inhibits Smurf2 Autoubiquitination and Substrate Ubiquitination
In Vitro and In Vivo
(A) Deletion of the C2 domain enhances Smurf2 autoubiquitination in vitro. In vitro autoubiquitination assays using bacterially expressed and purified
wild-type Smurf2, Smurf2 DC2mutant, or Smurf2 HECT domain were analyzed by immunoblotting with a-Smurf2 (top panel) and a-Ub antibody (bot-
tom panel).
(B) Mutations in the C2 domain designed to interfere with HECT domain binding enhance Smurf2 autoubiquitination. In vitro autoubiquitination assays
using bacterially expressed and purified wild-type Smurf2, DC2 mutant, and C2 domain mutants in the context of full-length Smurf2 were analyzed
after a reaction time of 1 hr by immunoblotting with a-Ub antibody (top panel, ‘‘In vitro reaction’’). Equivalent Smurf2 levels in the starting material
(‘‘Totals’’) were confirmed by immunoblotting with a-Smurf2 antibody (bottom panel).
(C) C2 domain deletion and impaired interactions between the C2 and HECT domains destabilize Smurf2 in vivo in a manner that is dependent on the
active site cysteine. HEK293T cells were transiently transfected with empty vector, Flag-tagged wild-type Smurf2, the DC2 mutant or C2 domain656 Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc.
domain binding (Figure S2A). In contrast, mutations of indi-
vidual basic residues in the interface had modest or no ef-
fect. Thus, interfering with the interface between the C2
and HECT domains enhances Smurf2 autoubiquitination.
To further examine whether full-length and DC2 Smurf2
contain the same number of ubiquitination sites, we car-
ried out autoubiquitination assays using wild-type, DC2,
F29/30A, or catalytically inactive (CA) Smurf2 in combina-
tion with either wild-type or lysine-less (K0) Ub (Figure S7).
In contrast to wild-type Ub, K0 Ub cannot form polyUb
chains. Both the DC2 and F29/30A Smurf2 mutants
formed discriminate monoubiquitinated species conju-
gated with up to three K0 Ub moieties. This suggests
that both full-length and DC2 Smurf2 contain three major
ubiquitination sites. In contrast, we detected no ubiquiti-
nation of wild-type Smurf2 using wild-type and K0 Ub.
This is likely due to the C2 domain inhibiting Ub thioester
formation and the less efficient use of K0 Ub in HECT-
domain-mediated ubiquitination (Woelk et al., 2006). Of
note, preliminary mass spectrometric analyses of the
monoubiquitinated Smurf2 species indicate that none of
the three major ubiquitination sites maps to the interaction
surface of the C2 and HECT domains (unpublished data).
The Smurf2 C2 and HECT Domains Interact
in an Intramolecular Manner
To examine whether the interaction between the Smurf2
C2 and HECT domains occurs in an intra- or intermolecu-
lar manner, we next testedwhether addition of the isolated
Smurf2 C2 domain inhibits autoubiquitination of the DC2
mutant in trans (Figure S8A). While the low level of auto-
ubiquitination of wild-type Smurf2 was virtually unaffected
by the presence of increasing amounts of isolated C2 do-
main, the levels of autoubiquitinated DC2 mutant de-
creased with increasing concentrations of isolated C2
domain. Based on this result, we next explored whether
the catalytically inactive (CA) Smurf2 inhibits autoubiquiti-
nation of the constitutively active F29/30A mutant. If the
C2 and HECT domains interacted in cis, the C2 domain
of the Smurf2 CA mutant should be engaged with the
ligase-dead CA HECT domain and therefore be unable
to inhibit autoubiquitination of the F29/30A mutant. In-
deed, we observed that the presence of increasing
amounts of the CA mutant had no effect on the activity
of F29/30A Smurf2 (Figure S8B), whereas the isolatedC2 domain efficiently inhibited the F29/30A mutant
(Figure S8C). In addition, examinations by size-exclusion
chromatography revealed that the elution volumes of
wild-type and DC2 Smurf2 are consistent with both
Smurf2 variants being monomeric in solution (Figures
S8D–S8E). Altogether, these results indicate that the inter-
action between theC2 andHECT domains serves an auto-
inhibitory function.
The Inhibitory C2 and HECT Domain Interaction
Protects Smurf2 from Degradation in Cells
To test whether the in vitro analysis of Smurf2 activity has
relevance for Smurf2 function in vivo, we examined
steady-state levels of various Smurf2 variants by immuno-
blotting HEK293T cell lysates (Figure 4C). We transiently
transfected HEK293T cells with Flag-tagged wild-type
Smurf2, the DC2 mutant, and four C2 domain mutants in
the context of both a wild-type HECT domain and the re-
spective inactive CA mutant. The transfected cells were
grown overnight in the presence and absence of the pro-
teasome inhibitor LLnL. In the case of wild-type Smurf2,
the presence of proteasome inhibitor had no effect on
Smurf2 steady-state levels. Similarly, the R31A and K83/
84E mutants, which failed to enhance Smurf2 autoubiqui-
tination in vitro, were unaffected by proteasome inhibition.
In contrast, each of the DC2, the F29/30A, and the T56/
L57A mutants displayed low steady-state levels that
were substantially enhanced by blocking proteasome
function. This effect was confirmed to be dependent on
autocatalytic activity since the steady-state levels of the
respective CA mutants were unaffected by the presence
of proteasome inhibitor (Figure 4C). Therefore, interfering
with the interaction between the C2 and HECT domains
destabilizes Smurf2 proteins in cells in a manner that is
dependent on the catalytic cysteine.
Interfering with the C2 and HECT Domain
Interface Enhances Smurf2 Activity toward the
Small GTPase RhoA
To investigate whether the interaction between the C2 and
HECT domains regulates substrate ubiquitination in trans,
we examined the ubiquitination activity of wild-type, F29/
30A, or catalytically inactive (CA) Smurf2 toward the small
GTPase RhoA, which is a known substrate of the closely
related Smurf1 enzyme (Wang et al., 2003). Levels ofmutants in the context of full-length Smurf2 and their respective catalytically inactive (CA) mutants. The cells were grown overnight in the presence or
absence of proteasome inhibitor (LLnL). Smurf2 steady-state levels in total cell lysates were determined by immunoblotting with a-Flag antibody.
(D) Impaired interactions between the C2 and HECT domains enhance RhoA ubiquitination in trans. Bacterially expressed and purified Flag-tagged
RhoA and wild-type, F29/30A, or catalytically inactive (CA) Smurf2 were subjected to in vitro ubiquitination as described (Wang et al., 2006). Levels of
Ub adducts and unmodified RhoA were detected with a-Ub and a-Flag antibody, respectively.
(E) Expression of constitutively active F29/30A, but not wild-type or catalytically inactive (CA) F29/30A Smurf2, decreases RhoA steady-state levels
in vivo. HEK293T cells were transiently transfectedwith empty vector, Flag-taggedRhoA alone, or in combination withwild-type, F29/30A, or F29/30A
CA Flag-tagged Smurf2. RhoA and Smurf2 steady-state levels in total cell lysates were determined by immunoblotting with a-Flag antibody.
(F) The N-terminal domain of Smad7 inhibits C2 domain binding to the HECT domain. Purified His6-HECT domain and increasing amounts of Smad7
NTD were incubated with purified, glutathione Sepharose-immobilized GST, or GST-C2 domain fusion protein. HECT domain binding to the C2 do-
main was detected by immunoblotting with a-His5 antibody (‘‘In vitroGST pull-down’’ panel). Equivalent His6-HECT, GST, and GST-C2 domain levels
in the starting material were confirmed by immunoblotting with a-His5 antibody and Ponceau S staining, respectively, while increasing concentrations
of Smad7 NTD were confirmed by immunoblotting with a-Smad7 antibody (‘‘Totals’’ panels).Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc. 657
unmodified and ubiquitinated Flag-tagged RhoA were an-
alyzed after immunoprecipitation using a-RhoA and a-Ub
antibodies (Figure 4D). While the level of unmodified RhoA
did not change upon addition of wild-type or CA Smurf2
(Figure 4D, bottom panel), RhoA was efficiently ubiquiti-
nated by the F29/30A Smurf2 mutant as revealed by the
significant decrease of unmodified RhoA levels
(Figure 4D, bottom panel) and the appearance of ubiquiti-
nated species in the presence of the Smurf2 F29/30A
mutant (Figure 4D, top panel).
To examine Smurf2-dependent RhoA degradation
in vivo, HEK293T cells were transiently transfected with
Flag-tagged RhoA together with either Flag-tagged wild-
type, F29/30A, or F29/30A CA Smurf2. Consistent with
the in vitro RhoA ubiquitination assays (Figure 4D) and pre-
vious observations (Wang et al., 2003), RhoA steady-state
levels were unaffected by the presence of wild-type
Smurf2 (Figure 4E). In contrast, RhoA was significantly de-
stabilized in the presence of the gain-of-function F29/30A
mutant in a manner that was dependent on the catalytic
cysteine. Although initial studies with Smurf1 and Smurf2
suggested that RhoA is a Smurf1-specific target
(Schwamborn et al., 2007; Wang et al., 2003), our in vitro
and in vivo studies establish that Smurf2 can target
RhoA for ubiquitination. However, in contrast to Smurf1,
Smurf2 activity toward RhoA is restricted by the intramo-
lecular interaction between the Smurf2 C2 and HECT do-
mains. While the sequences of the C2 and HECT domains
are highly conserved between Smurf1 and Smurf2, they
are not identical (92% identity for the C2 domain and
85% identity for the HECT domain). Thus, the differential
regulation of Smurf1 and Smurf2 toward RhoA may be
due to the distinct residues in these domains. In addition,
there is considerable divergence in the region between the
C2 and HECT domains of Smurf1 and Smurf2. In particular
the longer intervening sequence in Smurf2, which con-
tains a third WW domain not found in Smurf1, may allow
the C2 domain to achieve the correct orientation to confer
intramolecular inhibition on the HECT domain. Thus, inter-
fering with the interface between the C2 and HECT do-
mains stimulates Smurf2 autoubiquitination and substrate
ubiquitination in vitro and promotes Smurf2 and RhoA
degradation in cells.
The N-Terminal Domain of Smad7 Antagonizes
the Interaction between the Smurf2 C2
and HECT Domains
The adaptor protein Smad7 plays a critical role in the reg-
ulation of Smurf-dependent ubiquitination by coupling
HECT domain activity to substrate recruitment (Kavsak
et al., 2000; Ogunjimi et al., 2005). Accordingly, coexpres-
sion of Smad7 with Smurf2 destabilizes Smurf2 protein via
autoubiquitination (Ogunjimi et al., 2005), suggesting that
in addition to facilitating E2 recruitment, Smad7 might re-
lieve C2 domain-dependent autoinhibition. Therefore, we
tested whether the Smad7 N-terminal domain (NTD) could
compete with the C2 domain for HECT domain binding. To
separate Smurf2 activation due to NTD-mediated en-658 Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc.hancement of E2 binding (Ogunjimi et al., 2005) from
that due to competition between the C2 domain and the
NTD for HECT domain binding, we performed GST pull-
down experiments rather than in vitro autoubiquitination
assays. We incubated immobilized GST-tagged C2 do-
main with His6-tagged HECT domain and increasing
amounts of Smad7NTD and detected HECT domain bind-
ing to the C2 domain using a-His5 antibody (Figure 4F). As
expected from our NMR and biochemical studies (Figures
1, 3C–3E, and 4A–4E), the Smurf2 C2 domain interacted
with the HECT domain in the absence of Smad7 NTD.
However, increasing concentrations of Smad7 NTD inter-
fered with HECT domain binding to the C2 domain.
Unfortunately, low expression levels and solubility of the
Smad7 NTD precluded NMR analysis of the binding inter-
face between the Smad7 NTD and the Smurf2 HECT do-
main. However, coupled with the interaction between
the Smurf2 WW2–3 domains and a proline-rich motif di-
rectly C-terminal to the Smad7 NTD (Chong et al., 2006;
Kavsak et al., 2000) that facilitates NTD binding to the
Smurf2 HECT domain, the observed competition demon-
strates that Smad7 can relieve Smurf2 autoinhibition by
displacing the C2 domain from the HECT domain.
A Subset of C2-WW-HECT-Domain E3s Is
Regulated by Their C2 Domains
The common domain architecture suggests that the auto-
inhibition mechanism found for Smurf2 may be conserved
in other C2-WW-HECT-domain E3s. To test whether auto-
inhibition by their C2 domains regulates Nedd4/Rsp5p-
family members other than Smurf2, we performed auto-
ubiquitination assays with Rsp5p, Nedd4-1, AIP4, and
WWP2 enzymes and their respective DC2 mutants (Fig-
ure 5). Levels of unmodified and ubiquitinated protein
were detected by SDS-PAGE, immunoblotted with a-Ub
antibody, and quantified by chemiluminescence imaging.
As for Smurf2, wild-type Nedd4-1 and WWP2 enzymes
showed low ubiquitination levels that were significantly
enhanced upon deletion of their C2 domains (Figure 5).
In contrast, we detected almost no difference in the autou-
biquitination efficiency for Rsp5p and AIP4 in the absence
or presence of their C2 domains (Figure 5). Ub thioester
assays performed with the truncated wild-type and DC2
Nedd4/Rsp5p-family proteins (4aa or –5aa in the case
of Nedd4-1) confirmed that the Ub thioester formation in
Rsp5p is not regulated by its C2 domain (data not shown).
Unfortunately, Ub thioester assays for the other C2-WW-
HECT E3s were inconclusive because the full-length pro-
teins were ill behaved during SDS-PAGE under nonreduc-
ing conditions (data not shown).
Consistent with these results, deletion of the C2 domain
in AIP4/Itch and Rsp5p has no significant effect on AIP4
autocatalytic activity or Rsp5p activity toward Fur4p and
Gap1p (Gallagher et al., 2006; Springael et al., 1999;
Wang et al., 2001). Furthermore, wild-type Rsp5p is
known to efficiently form Ub thioester adducts and to
ubiquitinate itself (Salvat et al., 2004). These results sup-
port the notion that Rsp5p and AIP4 are not regulated by
Figure 5. A Subset of C2-WW-HECT-
Domain E3s Is Regulated by Their C2
Domains
(A) Bacterially expressed and purified wild-
type and DC2 C2-WW-HECT-domain E3s
(Rsp5p, Nedd4-1, AIP4, and WWP2) were
used for in vitro autoubiquitination assays in
the absence or presence of E1 enzyme. For-
mation of E3-Ub adducts was detected after
a reaction time of 1 hr by immunoblotting with
a-Ub antibody (top panel), while E3 levels
were detected by Ponceau S staining (bottom
panel).
(B) E3-Ub adduct formation in wild-type and
DC2 C2-WW-HECT-domain E3s (Smurf2,
Rsp5p, Nedd4-1, AIP4, and WWP2) was quan-
tified by chemiluminescence imaging using
a-Ub immunoblots. Ubiquitination levels of
wild-type and DC2 Smurf2 were quantified af-
ter a reaction time of 1 hr using experiments
shown in Figure 4A (bottom panel). Autoubiqui-
tination efficiencies were normalized to those
of the wild-type enzymes and are plotted as
the mean ± SE of triplicates from representa-
tive experiments.their C2 domains. In contrast, human Nedd4-1 lacking the
C2 domain downregulates the epithelial sodium channel
ENaC more potently in vivo than the wild-type enzyme
(Kamynina et al., 2001; Snyder et al., 2001). This suggests
that the C2 domain of Nedd4-1 has an inhibitory function.
Altogether, these studies define two subclasses of C2-
WW-HECT-domain E3s that are distinguished based on
differential autoregulation by their C2 domains.
DISCUSSION
Ub protein ligases are a large family of modular proteins
that are essential for regulating the trafficking and degra-
dation of components of various signaling pathways.
Given their importance, it is not surprising that E3 enzymes
are subject tomultiple layers of regulation. However, since
most studies have focused on E3 regulation at the level of
substrate recognition, much remains to be learned about
the regulation of E3 activity itself. Here, we addressed
the role of intra- and intermolecular interactions in the reg-
ulation of the C2-WW-HECT-domain Ub ligase Smurf2.
We demonstrate that the N-terminal C2 domain interacts
with the C-terminal HECT domain in direct proximity to
the catalytic cysteine and inhibits Ub thioester formation
(Figures 3D–3E). Furthermore,weshow that theN-terminal
domain (NTD) of Smad7, which is an adaptor protein that
recruits Smurf2 to a number of its targets, disrupts the in-teraction between the Smurf2 C2 and HECT domains
(Figure 4F). We propose a model in which autoinhibition
of the Smurf2 HECT domain by the C2 domain protects
the steady-state level of the Ub ligase in cells and is re-
lieved by adaptor-mediated substrate targeting (Figure 6).
Preventing Futile Cycles of Autocatalytic
Ubiquitination and Degradation
Ub protein ligases can catalyze the ubiquitination of both
their substrates and themselves (Fang and Weissman,
2004; Huibregtse et al., 1995). In many cases, E3 autoubi-
quitination mediates their proteasome-dependent degra-
dation, suggesting that autoubiquitination represents
a regulatory mechanism to control the abundance of Ub
protein ligases in cells (Fang and Weissman, 2004; Gal-
lagher et al., 2006; Ogunjimi et al., 2005). In addition, non-
proteolytic functions have recently been described for E3
autoubiquitination. While the generation of mixed polyUb
chains by autoubiquitination protects the RING finger-
type E3 Ring1B from proteasome-dependent degradation
and activates it for substrate ubiquitination (Ben-Saadon
et al., 2006), autoubiquitination of Nedd4/Rsp5p-family
members has been identified as a critical determinant
for their ability to ubiquitinate Ub receptor proteins (Woelk
et al., 2006). Interestingly, in both cases E3 autoubiquitina-
tion is essential for substrate monoubiquitination.Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc. 659
Figure 6. Model for the Autoinhibition
and Activation of Smurf2 through Re-
lease of the N-Terminal C2 Domain
from the C-Terminal HECT Domain
In the nucleus, Smurf2 (blue) activity is inhibited
due to the intramolecular interaction between
the N-terminal C2 and the C-terminal catalytic
HECT domain. This interaction serves to pre-
serve the steady-state level of Smurf2 by pre-
venting futile cycles of autoubiquitination and
degradation. TGF-b-induced expression of
the adaptor protein Smad7 (orange) results in
complex formation between Smurf2 and
Smad7 (Kavsak et al., 2000). The interaction
with Smad7 activates the Smurf2 ligase as
the Smad7 NTD displaces the C2 domain
from the HECT domain. The activated Smurf2-
Smad7 complex can then target nuclear
substrates for Ub-dependent degradation or
is exported to the cytoplasm. In the cytoplasm,
the Smurf2-Smad7 complex associates with
activated TGF-b receptor complexes (TbR;
shown in green) at the membrane (depicted
as a black line) via the displaced C2 domain
and the Smad7 MH2 domain (Hayashi et al.,
1997) to target TGF-b receptor complexes,
Smad7 and Smurf2 for Ub-dependent degra-
dation and ultimately terminate TGF-b
signaling.However, the presence of active catalytic HECT do-
mains in Ub protein ligases raises an important ques-
tion as to how the premature autoubiquitination and deg-
radation of E3s are controlled. This can be critical to
prevent futile cycles of production and degradation of
Ub protein ligases and to ensure that the short-lived E3s
are sufficiently stable to gain access to their bona fide sub-
strates. This issue becomes particularly problematic for
Ub protein ligases such as Smurf enzymes that employ
a range of adaptor proteins to target their substrates
(Bonni et al., 2001; Kavsak et al., 2000). Smurf2 targets it-
self for Ub-dependent degradation (Figure 4C; Ogunjimi
et al., 2005). Our studies suggest that in the absence of
adaptor proteins and bona fide substrates, Smurf2 auto-
ubiquitination and degradation is prevented by intramo-
lecular association of the C2 domain with the catalytic
HECT domain (Figures 3, 4, and S8). This interaction is an-
tagonized by binding of the NTD of the adaptor protein
Smad7 to the Smurf2 HECT domain (Figure 4F). In addi-
tion, the Smad7 NTD further enhances the catalytic activ-
ity of the Smurf2 ligase by recruiting the E2, UbcH7, to the
HECT domain (Ogunjimi et al., 2005). By releasing C2-
mediated autoinhibition, stimulating E2 binding, and re-
cruiting Smurf targets, Smad7 functions at multiple levels
to control Smurf activity and ensure specificity in Smurf-
catalyzed ubiquitination.
C2 Domains Serve Autoinhibitory Functions
in a Subset of C2-WW-HECT Domain E3s
Using structural and biochemical studies, we have defined
an autoinhibitory mechanism for the HECT-type Ub ligase660 Cell 130, 651–662, August 24, 2007 ª2007 Elsevier Inc.Smurf2 that extends to other Nedd4/Rsp5p-family E3s.
We showed that interfering with the interface between
the Smurf2 C2 and HECT domains enables Ub thioester
formation and enhances Smurf2 autoubiquitination and
Smurf2 activity toward the small GTPase RhoA (Figures
3E and 4A–4E). Similarly, deletion of the C2 domain in
Nedd4-1 and WWP2 promotes their autoubiquitination
in vitro (Figure 5) and enhances downregulation of the epi-
thelial sodium channel ENaC by Nedd4-1 in vivo (Kamy-
nina et al., 2001; Snyder et al., 2001). In contrast, deletion
of the C2 domain in AIP4/Itch and Rsp5p has no signifi-
cant effect on their autocatalytic activities or Rsp5p activ-
ity toward Fur4p and Gap1p (Figure 5; Gallagher et al.,
2006; Springael et al., 1999; Wang et al., 2001). Thus,
while the mechanism of regulating E3 activity by interac-
tions between the C2 and HECT domains is relevant to
some Nedd4/Rsp5p-family members, it is not inclusive
of all C2-WW-HECT-domain E3s.
Finally, dysregulation of Ub-dependent degradation of
signaling proteins is associated with the development
and progression of cancer and other human diseases.
This has spurred considerable interest in modulating E3
activities as a specific means for developing anticancer
drugs (Hoeller et al., 2006). Our results show that the
Smurf2 HECT domain functions as a platform that orga-
nizes multiple protein-protein interactions to regulate its
catalytic activity. The structural information described in
this study therefore not only provides new insight into
the regulation of a subset of HECT-type E3s but also offers
various starting points for manipulating the activities of
these enzymes by small molecule inhibitors to target
them for cancer therapy.
EXPERIMENTAL PROCEDURES
Constructs, Mutagenesis, and Protein Purification
Smurf2 C2 domain (aa 10–140) was cloned by PCR from full-length
Smurf2 (Ogunjimi et al., 2005) and inserted into modified pET24d vec-
tors (G. Stier, EMBL Heidelberg) to express NusA-His6-tagged fusion
protein for NMR studies and His6-GST-tagged fusion protein for pro-
tein lipid overlay assays. Both constructs contain a TEV protease
cleavage site C-terminal to the purification tag. The Smurf2 DC2 mu-
tant (aa 141–748) was cloned by PCR from full-length Smurf2, inserted
into a modified pCMV5b vector for transfection (see below), and sub-
cloned into a modified pGEX4T-1 vector for bacterial expression
(Ogunjimi et al., 2005). Full-length Smurf2 mutants (F29/30A, R31A,
T56/L57A, K83/84E, H86A, and K87/88E) used in in vitro ubiquitination
assays were generated by QuikChange (Stratagene) from wild-type
Smurf2 in a modified pGEX4T-1 vector (Ogunjimi et al., 2005) as
PCR template. The same construct served as PCR template to intro-
duce a stop codon by QuikChange (Stratagene) into full-length Smurf2
to produce GST-tagged C2 domain (aa 1–140) for ubiquitination as-
says and GST pull-down experiments. Bacterially expressed GST-
Flag-RhoA fusion protein was purified as described (Wang et al.,
2006). For mammalian cell assays, Flag-tagged C2 domain mutants
in the context of full-length Smurf2 were generated by QuikChange
(Stratagene) fromwild-type Smurf2 in amodified pCMV5b vector (Kav-
sak et al., 2000), digested with SalI (Fermentas) and Bsu36I (New En-
gland Biolabs), and inserted into the original pCMV5b vectors contain-
ing wild-type and C716A Smurf2 digested with the same restriction
enzymes.
Wild-type andDC2Smurf2 truncated by four residues from the C ter-
minus (‘‘4aa’’) were cloned by PCR and inserted into pProExHTb vec-
tors for bacterial expression. Wild-type, ‘‘4aa’’ (‘‘5aa’’ in the case of
Nedd4-1), DC2, and DC2-4aa (5aa) constructs of other Nedd4/
Rsp5p-family E3s were cloned from S. cerevisiae genomic DNA for
Rsp5p, from human Nedd4-1 cDNA (KIAA0093; Kazusa DNA Re-
search Institute), AIP4 (T. Pawson), and WWP2 plasmid DNA and
inserted into pProExHTb vectors for bacterial expression, while the
DNA sequence of human Ub was inserted into a modified pET24d vec-
tor (G. Stier) to yield His6-GST-tagged fusion protein. All His6-tagged
fusion proteins were purified using standard methods. All clones
were verified by DNA sequencing.
All NMR methods are described in the Supplemental Data.
Reagents, In Vitro, and In Vivo Assays
Antibodies and their suppliers were: a-Ub (P4D1; Santa Cruz); a-His5
(QIAGEN); a-Flag (M2; Sigma); a-RhoA (Santa Cruz); and a-Smad7/
N19 (Santa Cruz). a-Smurf2 antibodies were generated as described
(Kavsak et al., 2000).
For protein lipid overlay assays, phospholipid membranes (Echelon
Biosciences) were incubated with GST-tagged Smurf2 C2 domain for
2 hr at 4C. Membranes were washed in 13 TBS-T buffer containing
EGTA and bound C2 domain detected by immunoblotting using GST
antibody. All in vitro ubiquitination andUb thioester assayswere carried
out in 15 ml reaction buffer (50 mM Tris [pH 7.5], 10 mM MgCl2, and
50mMDTTsupplementedwith 3mMATP; 63, 53, or 2315ml reactions
where incubation times, protein concentrations, or SDS-PAGE buffer
[±DTT]were varied) using 85nM rabbit E1 (BostonBiochem), bacterially
expressed and purified E2 (40 mMUbcH7), 66 mMwild-type Ub with or
without N-terminal His6-GST-tag or Lys-less (K0) Ub (BostonBiochem),
and 1 mM E3. Bacterially expressed and purified RhoA was used at
a concentration of 1 mM and was immunoprecipitated using a-Flag an-
tibody as described (Wang et al., 2006). All reactions were incubated at
room temperature for 1 hr (unless stated otherwise; autoubiquitination
assays) or 10 min (Ub thioester assays). Protein levels were in general
detected by Ponceau S staining, while ubiquitinated species were de-
tected using a-Smurf2 and/or a-Ub antibody.
For GST pull-down experiments, bacterially expressed GST or GST-
tagged C2 domain were bound to GST beads from total cell lysatesand washed extensively with 13 PBS supplemented with 1 mM
PMSF and 5 mM b-mercaptoethanol. Bacterially expressed Smad7
NTD (aa 1–201) was purified as described (Ogunjimi et al., 2005). In-
creasing amounts of untagged Smad7 NTD were incubated at 4C
for 1 hr with GST or GST-tagged C2 domain bound to GST beads in
the presence or absence of His6-HECT domain. GST beads were
washed four times in 50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 0.1% Triton X-100, 1 mMPMSF, and 5mM b-mercaptoethanol.
Bound protein was analyzed by SDS-PAGE and immunoblotting using
a-His5 antibody. All in vitro experiments were repeated at least three
times.
For in vivo assays, Flag-tagged RhoA and/or wild-type and mutant
Smurf2 were transfected in HEK293T cells as described (Kavsak
et al., 2000; Wang et al., 2006). For Smurf2 degradation assays, trans-
fected cells were grown overnight in the presence or absence of 20 mM
LLnL (BostonBiochem). Smurf2 and RhoA steady-state levels were an-
alyzed by SDS-PAGE and immunoblotting using a-Flag antibody.
Data Deposition
Chemical shift assignments and protein coordinates for the Smurf2 C2
domain have been deposited in the Biological Magnetic Resonance
Bank (accession code: 15306) and in the Protein Data Bank (accession
code: 2JQZ).
Supplemental Data
Supplemental Data include one table, Experimental Procedures, Ref-
erences, and eight figures and can be found with this article online at
http://www.cell.com/cgi/content/full/130/4/651/DC1/.
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